Back

Association between SGLT2 inhibitor use and heart failure outcomes in anthracycline-exposed patients: a meta-analysis

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Tackling toxicity in heart failure Cardiotoxicity of Drugs and Other Therapies ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Lissette Haydee Garcia-Mena

National Institute of Cardiology Ignacio Chavez, Mexico City (Mexico)

4 More presentations in this session

Presentation thumbnail
HFE variants modify the distribution and prognostic associations of iron deficiency in heart failure
Mr S. Majoor (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Regulatory role of Uncoupling Protein 2 (UCP2) in a rat model of chronic tobacco smoke-induced cardiopulmonary comorbidity
Mr L. Deres (Pecs, HU)
Abstract Slides Video
Presentation thumbnail
AI-assisted longitudinal cardiac phenotyping facilitated identification of domain-specific remodeling trajectories in fabry cardiomyopathy
Doctor K. Sung (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Sex determines myocardial iron load and its hemodynamic correlates in advanced heart failure
Ms Z. Wojdynska (Warsaw, PL)
Abstract Slides Video

Access the full session

Session thumbnail
Tackling toxicity in heart failure

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Timing of sacubitril/valsartan initiation and cardiovascular outcomes in anthracycline-treated cancer patients
29 August 2026
thumbnail
Congress Presentation
Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
19 May 2025
thumbnail
Congress Presentation
In-hospital treatment intensification and outcomes in patients hospitalised for worsening heart failure in the current era of guideline-directed medical treatment
28 August 2026
thumbnail
Congress Presentation
Hyperkalemia and its outcome implications in patients with heart failure with reduced ejection fraction: results from a single-center cohort
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources